Chemoinformaics analysis of 8-O-methyl-7-hydroxyaloin A
| Molecular Weight | 448.424 | nRot | 4 |
| Heavy Atom Molecular Weight | 424.232 | nRig | 22 |
| Exact Molecular Weight | 448.137 | nRing | 4 |
| Solubility: LogS | -3.522 | nHRing | 1 |
| Solubility: LogP | 0.83 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
| nHA | 10 | APOL | 60.763 |
| nHD | 7 | BPOL | 28.417 |
| QED | 0.256 |
| Synth | 4.214 |
| Natural Product Likeliness | 2.019 |
| NR-PPAR-gamma | 0.724 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.403 |
| HIA | 0.985 |
| CACO-2 | -6.158 |
| MDCK | 0.00000427 |
| BBB | 0.049 |
| PPB | 0.906791 |
| VDSS | 0.856 |
| FU | 0.151611 |
| CYP1A2-inh | 0.13 |
| CYP1A2-sub | 0.061 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.191 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.17 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.017 |
| CL | 4.015 |
| T12 | 0.756 |
| hERG | 0.038 |
| Ames | 0.668 |
| ROA | 0.03 |
| SkinSen | 0.821 |
| Carcinogencity | 0.025 |
| EI | 0.066 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.344 |
| Antiviral | Yes |
| Prediction | 0.894436 |